During the last few years, an impressive amount of experimental studies and clinical trials have dealt with a variety of distinct topics in allergic skin diseasesespecially atopic dermatitis. In this update, we discuss selected recent data that provide relevant insights into clinical and pathophysiological aspects of allergic skin diseases or discuss promising targets and strategies for the future treatment of skin allergy. This includes aspects of barrier malfunction and inflammation as well as the interaction of the cutaneous immune system with the skin microbiome and diagnostic procedures for working up atopic dermatitis patients. Additionally, contact dermatitis, urticaria, and drug reactions are addressed in this review. This update summarizes novel evidence, highlighting current areas of uncertainties and debates that will stimulate scientific discussions and research activities in the field of atopic dermatitis and skin allergies in the future.A variety of distinct topics in allergic skin diseases and especially atopic dermatitis (AD) has been addressed in the biomedical literature published during the last few years. Recent work has focused on many clinical and pathophysiological aspects of allergic skin diseases, discussing promising targets and strategies for the future treatment of skin allergies (1, 2). In this review, we summarize novel evidence and highlight current areas of research in AD, contact dermatitis, urticaria, drug reactions, and other allergic skin diseases.
Risk factors and severity scoring of atopic dermatitisAD is a common, clinically defined skin disease frequently associated with allergic rhinitis, asthma, and immunoglobulin E (IgE)-mediated food reactions (3, 4). The high variability of clinical phenotype and severity, genetic background, and known pathomechanisms strongly suggests a high degree of pathophysiological heterogeneity (5). Although the clinical pattern of eczematous skin lesion is relatively uniform, AD often shows distinct progression patterns, hence requiring personalized prevention and management strategies (5).Determinants of AD were extracted from the public-use files of the German Interview and Examination Survey for Children and Adolescents (KIGGS) study, a nationwide cross-sectional representative survey including 17 641 German children aged 0-17 years with a response rate of 66.6% (6). The weighted prevalence of ever physician-diagnosed eczema was 13.2% (95% CI 12.5-13.9%), with significant positive associations between parental allergies (OR 1.94, 95% CI 1.72-2.19), parent-reported infection after birth (OR 1.45, 95% CI 1.05-2.00), and parent-reported jaundice after birth (OR 1.27, 95% CI 1.04-1.54). Being a migrant (OR 0.63, 95% CI 0.49-0.80) and keeping a dog (OR 0.78, 95% CI 0.64-0.96) showed significant inverse associations with eczema. Other lifestyle (alcohol consumption during pregnancy) and environmental factors (mold on the walls, pets) Abbreviations AD, atopic dermatitis; CU, chronic spontaneous urticaria; DOCK8, dedicator of cytokinesis 8 ...